July 2016, Vol 6, No 7

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) permanently eliminates the sustainable growth rate formula and provides annual payment adjustments through 2019. Although this law may ultimately stabilize Medicare physician reimbursement, oncologists are currently working to prepare for this long-term transition. Read More ›

Liquid Biopsies Show High Correlation with Tissue Biopsy for Genetic Mutations

By Wayne Kuznar

Summer Homework for Oncology: Successes and Failures in Oral Drugs Management

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

Support Services Provide Some Relief from Financial Distress of Cancer Treatment, but More Is Needed

By Meg Barbor, MPH; Meg Barbor, MPH

At the 2016 Community Oncology Alliance conference, Patricia J. Goldsmith, Chief Executive Officer of CancerCare, and Alan J. Balch, PhD, Chief Executive Officer of the Patient Advocate Foundation (PAF), discussed the services their organizations provide for patients, highlighting the cost barriers for patients with cancer. Read More ›

Integrating Survivorship Care in Oncology: A Conversation with Patricia Ganz, MD

Survivorship Care

Select Ongoing Trials Currently Enrolling Patients with Leukemia

Clinical Trials Tracker

Updated NCCN Multiple Myeloma Guideline Expands Patient Eligibility and Therapeutic Options

By Wayne Kuznar

NCCN Guideline Updates, Multiple Myeloma, Hematologic Malignancies, National Comprehensive Cancer Network (NCCN)

Aggressive End-of-Life Care Still Offered to Younger, Non-Medicare Patients with Cancer

By Phoebe Starr